RetiNov

📍 Bègles, France👥 8 employees💰 Last funded Sep 2023
Hospitals and Health Care🌐 macutest.com
Website LinkedIn
We provide a digital platform called MacuTest to predict your risk of progressing to the advanced stages of Age-related Macular Degeneration (AMD), a blinding and incurable disease. According to your risk, we provide you with personalised lifestyle recommendations to help you preserve your vision. Our technology was developed by the Eye Risk consortium in the framework of the European program Horizon 2020. www.eyerisk.eu
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in RetiNov?
RetiNov has 1 investors on record on gritt.io.
When did RetiNov last raise funding?
The most recent investment in RetiNov recorded on gritt.io was in September 2023.
What industry is RetiNov in?
RetiNov operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is RetiNov based?
RetiNov is headquartered in Bègles, France.